Feed BJDX
BJ

Bluejay Diagnostics, Inc.

BJDX · NASDAQ

$0.94 +9.85% (+$0.08)
1M +1.00%
Market Cap $879.6K
P/E Ratio -
Div. Yield -
ROE 125.01%

Bulios Fair Price

$1.14

21.0% upside

Trenutna cena

$0.94

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BJDX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/B 0.09x
PEG N/A
P/S N/A
Growth
0 /100
Declining
Book val. growth 19.70%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor
ROE 125.01%
ROA 63.04%
Asset turnover 0.00x
Debt
69 /100
Low
Current ratio 4.64x
Int. coverage -18,786.30x
Debt/Equity 0.01x
Stability
38 /100
Moderate
EPS volatility 77.72%
Profitable years 0
Beta 0.91x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BJDX
Online

O podjetju

Bluejay Diagnostics, Inc. (BJDX) is a company focused on diagnostic technologies and innovative medical tests. Its products and technologies are geared towards early detection and diagnosis of various diseases and health conditions. Bluejay Diagnostics aims to develop accurate, fast, and user-friendly diagnostic tests that can be used in hospitals, clinics, laboratories, and even at home by patients. The company emphasizes innovation and research to provide healthcare professionals and patients with reliable and effective tools for diagnosing and treating various diseases. Bluejay Diagnostics aims to contribute to improving the health status and quality of life of patients. Shares of Bluejay Diagnostics, Inc. (BJDX) can represent an interesting investment opportunity for those who believe in the growth potential of diagnostic technologies and the innovative healthcare industry.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Indranil Dey

Employees

6

Headquarters

Acton

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

54d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.